Aspen Park Pharmaceuticals Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Employees
-
2
- Latest Deal Type
-
M&A
Aspen Park Pharmaceuticals General Information
Description
Developer of novel therapies for premature ejaculation in men. The company focuses on the development and commercialization of novel therapies for men's health diseases and conditions, including male secondary hypogonadism, prostate cancer, and sexual dysfunction.
Contact Information
Website
www.aspenparkpharma.comCorporate Office
- 944 Park Avenue
- New York, NY 10028
- United States
Corporate Office
- 944 Park Avenue
- New York, NY 10028
- United States
Aspen Park Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 31-Oct-2016 | Completed | Generating Revenue | |||
| 2. Seed Round | 31-Mar-2016 | Completed | Startup | |||
| 1. Early Stage VC (Series A) | 10-Dec-2014 | Completed | Startup |
Aspen Park Pharmaceuticals Patents
Aspen Park Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2017260505-A1 | Delayed release oral tamsulosin hydrochloride | Inactive | 04-May-2016 | ||
| CA-3023106-A1 | Delayed release oral tamsulosin hydrochloride | Inactive | 04-May-2016 | ||
| EP-3452016-A1 | Delayed release oral tamsulosin hydrochloride | Inactive | 04-May-2016 | ||
| US-20190133977-A1 | Delayed release oral tamsulosin hydrochloride | Inactive | 04-May-2016 | ||
| WO-2017192808-A1 | Delayed release oral tamsulosin hydrochloride | Inactive | 04-May-2016 | A61K31/18 |
Aspen Park Pharmaceuticals Signals
Aspen Park Pharmaceuticals FAQs
-
When was Aspen Park Pharmaceuticals founded?
Aspen Park Pharmaceuticals was founded in 2014.
-
Where is Aspen Park Pharmaceuticals headquartered?
Aspen Park Pharmaceuticals is headquartered in New York, NY.
-
What is the size of Aspen Park Pharmaceuticals?
Aspen Park Pharmaceuticals has 2 total employees.
-
What industry is Aspen Park Pharmaceuticals in?
Aspen Park Pharmaceuticals’s primary industry is Therapeutic Devices.
-
Is Aspen Park Pharmaceuticals a private or public company?
Aspen Park Pharmaceuticals is a Private company.
-
What is Aspen Park Pharmaceuticals’s current revenue?
The current revenue for Aspen Park Pharmaceuticals is .
-
How much funding has Aspen Park Pharmaceuticals raised over time?
Aspen Park Pharmaceuticals has raised $1.25M.
-
When was Aspen Park Pharmaceuticals acquired?
Aspen Park Pharmaceuticals was acquired on 31-Oct-2016.
-
Who acquired Aspen Park Pharmaceuticals?
Aspen Park Pharmaceuticals was acquired by Veru.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process